No Data
No Data
No Data
No Data
No Data
Changes in Hong Kong stocks | Changjiang Life Technology (00775) rises by nearly 30%. The company will display cancer vaccine research data and cancer vaccine model research cooperation data
Changjiang Life Science (00775) rose by nearly 30%. As of press release, it rose 21.88% to HK$0.39, with a turnover of HK$13.1371 million.
Zhitong FinanceApr 8 02:16 ET
Changes in Hong Kong stocks | Changjiang Life Technology (00775) rose 20% in the afternoon to present cancer vaccine model research cooperation data at the AACR annual meeting
The Zhitong Finance App learned that Changjiang Life Technology (00775) rose 20% in the afternoon. As of press release, it had risen 9.68% to HK$0.34, with a turnover of HK$5.9977 million. According to the news, Changjiang Life Science announced in the afternoon that, together with partner XtalPi (XtalPi), it will show how its artificial intelligence driven (AI) platform can be applied to design cancer vaccines at the American Association for Cancer Research (AACR) 2024 Annual Meeting to be held in San Diego, USA. The two sides discovered that the AI model developed in the research collaboration can significantly improve the design of novel antigen peptide vaccines. In advance
Zhitong FinanceApr 5 01:34 ET
Changjiang Life Science (00775.HK): New data from preclinical research on KRAS and PD-L1 research cancer vaccines will be exhibited at the AACR 2024 annual meeting
Gelonghui, April 5, 丨 Changjiang Life Technology (00775.HK) announced that the company will present two sets of new pre-clinical research data on rat sarcoma virus oncogene (KRAS) and cell-mediated death-ligand 1 (PD-L1) research cancer vaccines at the 2024 annual meeting of the American Association for Cancer Research (AACR) to be held in San Diego, California, USA. According to the disclosure, KRAS protein is commonly mutated in various cancers and is a key regulator of cell growth and survival, driving tumor growth by promoting uncontrolled cell reproduction and resistance to treatment. PD-L1 protein is
Gelonghui FinanceApr 5 00:10 ET
Investors Don't See Light At End Of CK Life Sciences Int'l., (Holdings) Inc.'s (HKG:775) Tunnel And Push Stock Down 26%
Unfortunately for some shareholders, the CK Life Sciences Int'l., (Holdings) Inc. (HKG:775) share price has dived 26% in the last thirty days, prolonging recent pain. Instead of being rewarded, sha
Simply Wall StMar 20 19:25 ET
Changjiang Life Science (00775.HK): Profit attributable to shareholders in 2023 HK$17.25 million
Gelonghui, March 19, 丨 Changjiang Life Technology (00775.HK) announced that for the year ended December 31, 2023, it achieved revenue of HK$5.323 billion, up 1% year on year; recorded profit attributable to shareholders of HK$17.25 million, down 87% year on year, with a basic profit of 0.18 cents per share. The business environment has been turbulent for the past three years. In 2021, as the coronavirus epidemic began to recede, the company promptly raised prices, streamlined operations and improved efficiency to mitigate the impact of inflation, labor shortages and supply chain disruptions. When central banks around the world raised interest rates sharply in 2022 to curb inflation
Gelonghui FinanceMar 19 05:48 ET
CKLIFE SCIENCES: ANNUAL RESULTS FOR 2023
Futu NewsMar 19 05:43 ET · Announcements
No Data
No Data